sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - imblokk neuromuskolari - il-prodotti terapewtiċi l-oħra kollha - it-treġġigħ lura ta 'imblokk newromuskolari kkawżat minn rocuronium jew vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - il-prodotti terapewtiċi l-oħra kollha - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
bovalto ibraxion
merial - virus ibr inattivat - immunoloġiċi għall-bovidae - bhejjem - immunizzazzjoni attiva tal-baqar biex tnaqqas is-sinjali kliniċi ta 'rhinotracheitis bovina infettiva (ibr) u l-eskrezzjoni tal-virus tal-kamp. , il-bidu ta 'l-immunità huwa ta' 14-il jum u t-tul ta 'l-immunità huwa ta' 6 xhur.
parvoduk
merial - parvovirus tal-papri muscovy ħaj attenwat - immunoloġiċi għall-aves, papri parvovirus, vaċċini virali Ħajjin - papri - immunizzazzjoni attiva ta 'papri biex jipprevjenu l-mortalità1 u biex tnaqqas it-telf ta' piż u l-leżjonijiet tal-parvovirosis tal-papri u l-marda ta 'derzsy. 1fl-assenza ta 'antikorpi derivati mill-omm.
profender
vetoquinol s.a. - emodepsajd, prazikwantel - prodotti kontra l-parassiti, insettiċidi u repellenti - dogs; cats - catsfor-qtates li jbatu minn, jew huma f'riskju minn infezzjonijiet kawżati minn parassiti diversi ikkawżati minn minn ħniex u dud ta ' l-ispeċi li ġejjin:minn ħniex (nematodi)toxocara cati (adulti maturi, adulti immaturi, l4 u l3);toxocara cati (larva l3) – it-trattament tal-qtates matul l-aħħar tat-tqala biex jipprevjenu lactogenic it-trażmissjoni lill-frieħ;toxascaris leonina (adulti maturi, adulti immaturi u l4);ancylostoma tubaeforme (adulti maturi, adulti immaturi u l4). dud (cestodes)dipylidium caninum (adulti maturi, adulti immaturi);taenia taeniaeformis (adult);echinococcus multilocularis (adult). lungwormsaelurostrongylus abstrusus (adulti). dogsfor klieb li qed isofru minn, jew huma f'riskju minn infezzjonijiet kawżati minn parassiti diversi ikkawżati minn minn ħniex u dud ta ' l-ispeċi li ġejjin:minn ħniex (nematodi):toxocara canis (adulti maturi, adulti immaturi, l4 u l3);toxascaris leonina (adulti maturi, adulti immaturi u l4);ancylostoma caninum (adulti maturi, adulti immaturi);uncinaria stenocephala (adulti maturi, adulti immaturi);trichuris vulpis (adulti maturi, adulti immaturi u l4);d-duda (cestodes):dipylidium caninum;taenia spp. ;echinococcus multilocularis (adulti maturi, adulti immaturi);echinococcus granulosus (adulti maturi, adulti immaturi).
velactis
ceva santé animale - cabergoline - prolactine tal-protease, genito sistema urinarja u l-ormoni tas-sess, oħra gynecologicals - għall-użu fil-merħla-programm tal-ġestjoni tal-baqar tal-ħalib bħala għajnuna fil-f'daqqa t-tnixxif-off mill-tnaqqis tal-produzzjoni tal-ħalib li:inaqqsu l-ħalib tnixxija mill-tnixxif off;jitnaqqas ir-riskju ta ' l-ġodda intramammarja l-infezzjonijiet matul il-perjodu xott;tnaqqas l-iskumdità.
neupopeg
dompé biotec s.p.a. - pegfilgrastim - neutropenia; cancer - immunostimulanti, - tnaqqis fit-tul tal-neutropenia u l-inċidenza tal-marda bid-deni neutropenia fil-pazjenti trattati ma chemotherapy ċitotossiċi għall-malignancy (bl-eċċezzjoni ta ' kronika myeloid lewċemja u myelodysplastic sindromi).
sevelamer carbonate winthrop (previously sevelamer carbonate zentiva)
sanofi b.v. - sevelamer carbonate - hyperphosphatemia; renal dialysis - il-prodotti terapewtiċi l-oħra kollha - sevelamer karbonat tal-winthrop huwa indikat għall-kontroll ta'l-iperfosfatemija fil-pazjenti adulti li qegħdin jirċievu l-emodijalisi jew dijalisi tal-peritonew. sevelamer karbonat tal-winthrop huwa indikat ukoll għall-kontroll ta'l-iperfosfatemija fil-pazjenti adulti b'mard kroniku tal-kliewi mhux fuq dijalisi mal-fosforu fis-serum > 1. 78 mmol / l. sevelamer karbonat tal-winthrop għandu jintuża fi ħdan kuntest ta ' metodu terapewtiku multiplu, li jistgħu jinkludu l-suppliment tal-kalċju, 1,25-dihydroxy vitamin d3 jew wieħed mill-analogi tiegħu biex jikkontrollaw l-iżvilupp tal-marda fl-għadam tal-kliewi.
symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - fibrożi ċistika - prodotti oħra tas-sistema respiratorja - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
sugammadex mylan
mylan ireland limited - sugammadex sodium - imblokk neuromuskolari - il-prodotti terapewtiċi l-oħra kollha - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.